AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹4.93 Cr |
Mar2024 | ₹5.68 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹47 Cr |
Mar2021 | ₹29 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹4.93 Cr | -13.20 | |
Mar2024 | ₹5.68 Cr | -50.37 | |
Mar2023 | ₹11 Cr | -75.76 | |
Mar2022 | ₹47 Cr | 60.86 | |
Mar2021 | ₹29 Cr | - |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹251.9 Cr | -8.3% | -9.2% | -49.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -8.3% |
-9.2% |
-49.9% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses